Company · Ownership research

Contineum Therapeutics, Inc. CTNM

CIK 0001855175

Form 3 statements with an event date from Nov 1, 2023 to Nov 7, 2026.

Insider trading Initial holdings Institutional holders

Some filings are submitted jointly by several insiders. The SEC form does not apportion the reported figures between them, so results include every joint filer.

Where insider ownership starts.

Form 3 is an initial ownership statement filed when someone becomes a reporting insider. These holdings do not mean they bought shares that day.

202413 of 13 statements

Holdings date	Insider	Initial holdings
Jun 24, 2024	Boyce Sarah Director	No securities reported	▾
May 30, 2024	Healy John Stephen General Counsel and Corp Sec	No securities reported	▾
May 20, 2024	Ignelzi Troy A. Director	No securities reported	▾
Apr 9, 2024	JOHNSON & JOHNSON · Johnson & Johnson Innovation - JJDC, Inc. 10% owner / 10% owner	1.98M shares	▾
Apr 4, 2024	Ware Olivia C Director	1 derivative holding	▾
Apr 4, 2024	Schimmelpennink Evert B. Director	2 derivative holdings	▾
Apr 4, 2024	Lyons-Williams Lori Director	2 derivative holdings	▾
Apr 4, 2024	Brady Todd R. Director	1 derivative holding	▾
Apr 4, 2024	Huhn Stephen L. CMO & Sr VP, Clinical Dev.	3 derivative holdings	▾
Apr 4, 2024	Slover Peter T Chief Financial Officer	3 derivative holdings	▾
Apr 4, 2024	Lorrain Daniel S. Chief Scientific Officer	2 stock holdings · 7 derivative holdings	▾
Apr 4, 2024	Stengone Carmine N. CEO and President · Director	11.61K shares · 4 derivative holdings	▾
Apr 4, 2024	Versant Ventures IV, LLC · Versant Venture Capital IV, L.P. · Versant Side Fund IV, L.P. · Versant Venture Capital VI, L.P. · Versant Vantage I, L.P. · Versant Vantage I GP, L.P. · Versant Ventures VI GP-GP, LLC · Versant Vantage I GP-GP, LLC · Versant Ventures VI GP, L.P. 10% owner / 10% owner / 10% owner / 10% owner / 10% owner / 10% owner / 10% owner / 10% owner / 10% owner	375.54K shares · 10 derivative holdings	▾

Showing 13 / 13 statements in 2024. The complete set is available through the API.

Contineum Therapeutics, Inc. · CTNM

Follow the people behind the trades.

Log in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and reach other datasets through the Akkru API.

Download CSV
Earlier filings
Advanced screening & filtering
API & AI access

Already have an account?

＋ New accounts get free API credits to explore data beyond ownership filings.

For AI agents & developers

The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account. For 2024, this page lists 13 of 13 statements.

Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP / CLI.

MCP  https://api.akkrudata.ai/mcp

akkru_initial_holdings
{"action":"list","ticker":"CTNM","page_size":20}

Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.

MCP endpoint: https://api.akkrudata.ai/mcp
API / MCP / CLI documentation: /documents
llms.txt: /llms.txt

Sources, coverage & how to read this data

Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.